Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2437353
Max Phase: Preclinical
Molecular Formula: C31H27ClN2O5
Molecular Weight: 543.02
Molecule Type: Small molecule
Associated Items:
ID: ALA2437353
Max Phase: Preclinical
Molecular Formula: C31H27ClN2O5
Molecular Weight: 543.02
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1ccc(NC(=O)c2ccc(Cl)cc2OC(=O)[C@H](Cc2ccccc2)NC(=O)OCc2ccccc2)cc1
Standard InChI: InChI=1S/C31H27ClN2O5/c1-21-12-15-25(16-13-21)33-29(35)26-17-14-24(32)19-28(26)39-30(36)27(18-22-8-4-2-5-9-22)34-31(37)38-20-23-10-6-3-7-11-23/h2-17,19,27H,18,20H2,1H3,(H,33,35)(H,34,37)/t27-/m0/s1
Standard InChI Key: NJJSVFVQYHIOQM-MHZLTWQESA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 543.02 | Molecular Weight (Monoisotopic): 542.1608 | AlogP: 6.34 | #Rotatable Bonds: 9 |
Polar Surface Area: 93.73 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: 2 | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 12.83 | CX Basic pKa: | CX LogP: 7.25 | CX LogD: 7.25 |
Aromatic Rings: 4 | Heavy Atoms: 39 | QED Weighted: 0.19 | Np Likeness Score: -1.01 |
1. Pauk K, Zadražilová I, Imramovský A, Vinšová J, Pokorná M, Masaříková M, Cížek A, Jampílek J.. (2013) New derivatives of salicylamides: Preparation and antimicrobial activity against various bacterial species., 21 (21): [PMID:24045008] [10.1016/j.bmc.2013.08.029] |
Source(1):